Vote Scores

Home / Companies / Ginkgo Bioworks Holdings, Inc. / 13 Jun 2024

Meeting · year to 30 June 2024356 filers reporting

Ginkgo Bioworks Holdings, Inc.: meeting of 13 Jun 2024

Votes reported on Form N-PX, item by item

356 Form N-PX filers reported votes at the Ginkgo Bioworks Holdings, Inc. meeting of 13 Jun 2024. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

7 nominees; 77.6% of reported votes for; 63 filers withheld from or voted against at least one nominee.

1,158 vote records from 88 filers. 1 of the 82 filers that marked the item either way voted against management. 6 filers reported this item without a management mark.

92.0% for1.1% against6.8% other1.2% against management88 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

488 vote records from 351 filers. 18 of the 323 filers that marked the item either way voted against management. 28 filers reported this item without a management mark.

0 filers reported share counts too large to be the holding described. No share split is published for this item. How that is decided

86.6% for4.6% against8.8% other5.6% against management351 filers
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

165 vote records from 86 filers. 0 of the 80 filers that marked the item either way voted against management. 6 filers reported this item without a management mark.

0 filers reported share counts too large to be the holding described. No share split is published for this item. How that is decided

93.0% for0.0% against7.0% other0.0% against management86 filers

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityForForFor
State Street and SPDRForForFor
American CenturyNo reportAgainst *No report
Franklin TempletonForForFor
InvescoForAgainst *For
EquitableForForFor
Charles SchwabForForFor
Nuveen and TIAAForForFor
John Hancock and ManulifeForForFor
Morgan Stanley, Eaton Vance and CalvertForForFor
J.P. MorganForForFor
Goldman SachsNo reportForNo report
PGIM and PrudentialForForFor
Northern Trust and FlexSharesForForFor
SEIForForFor
T. Rowe PriceForForFor
Lincoln FinancialForForFor
VoyaAgainst *ForFor
NationwideForForFor
Victory CapitalForForFor
Brighthouse FundsForForFor
Guggenheim and RydexForForFor
Columbia ThreadneedleNo reportForNo report
BNY MellonForForFor
PrincipalForForFor
Pacific Life fundsForForFor
TransamericaForForFor
AllianceBernsteinNo reportForNo report
PIMCONo reportForNo report
Janus HendersonNo reportForNo report
Neuberger BermanNo reportForNo report
American BeaconForForFor
Natixis and Loomis SaylesNo reportForNo report
BairdNo reportForNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Ginkgo Bioworks Holdings, Inc. meeting?

356 Form N-PX filers reported votes at the meeting of 13 Jun 2024. On say-on-pay, 18 of 323 voted against management (5.6%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Ginkgo Bioworks Holdings, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Ginkgo Bioworks Holdings, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Ginkgo Bioworks Holdings, Inc. with a meeting date within three days of 13 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.